Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review

Abstract Introduction A significant proportion of dementia is concretely estimated to be attributable to dementia with Lewy bodies (DLB)—one of the most common types of progressive dementia; however, there is a paucity of literature on this disease. We aimed to examine available evidence to gain a b...

Full description

Bibliographic Details
Main Authors: Amir Abbas Tahami Monfared, Genevieve Meier, Richard Perry, Darren Joe
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-09-01
Series:Neurology and Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1007/s40120-019-00154-7
_version_ 1811330796631359488
author Amir Abbas Tahami Monfared
Genevieve Meier
Richard Perry
Darren Joe
author_facet Amir Abbas Tahami Monfared
Genevieve Meier
Richard Perry
Darren Joe
author_sort Amir Abbas Tahami Monfared
collection DOAJ
description Abstract Introduction A significant proportion of dementia is concretely estimated to be attributable to dementia with Lewy bodies (DLB)—one of the most common types of progressive dementia; however, there is a paucity of literature on this disease. We aimed to examine available evidence to gain a better understanding of its treatment landscape, clinical management, and disease burden. Methods A systematic literature review captured any DLB studies that report on randomised controlled trials (RCTs), epidemiology, disease progression, and economic data. An additional targeted literature review captured studies reporting on clinical management and quality of life (QoL) in this disease. Publication date was limited to 1 January 2007–26 March 2018, with the exception for RCTs, where no time restrictions were applied. Findings Of the 3486 studies initially identified, 55 studies were eligible for inclusion. The studies were mainly from Europe (n = 29), the USA (n = 9), and Japan (n = 8). Mini-Mental State Examination and Neuropsychiatric Inventory scores were the most commonly reported clinical outcomes in RCTs (n = 14). The most frequently identified interventions reported in RCTs were donepezil and memantine. Patients with DLB typically reported worse outcomes in relation to efficacy and safety, cognitive impairment, survival, and QoL compared with those with Alzheimer’s disease (AD). Additionally, patients with DLB were associated with higher hospitalisation rates and cost of care. Furthermore, there is a reliance on a small number of consensus guidelines. Of these, only one set of guidelines (DLB Consortium) was developed specifically for DLB. Conclusion The paucity of data indicates an unmet need in this therapy area. Although several studies look into the clinical and pathological aspects of DLB, consensus guidelines and studies on healthcare utilisation in patients with dementia have largely focused on AD. Additionally, most of the findings were made in comparison with AD. Funding Eisai Inc.
first_indexed 2024-04-13T16:08:24Z
format Article
id doaj.art-b844ad56711243919549488eb18a6748
institution Directory Open Access Journal
issn 2193-8253
2193-6536
language English
last_indexed 2024-04-13T16:08:24Z
publishDate 2019-09-01
publisher Adis, Springer Healthcare
record_format Article
series Neurology and Therapy
spelling doaj.art-b844ad56711243919549488eb18a67482022-12-22T02:40:20ZengAdis, Springer HealthcareNeurology and Therapy2193-82532193-65362019-09-018228930510.1007/s40120-019-00154-7Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature ReviewAmir Abbas Tahami Monfared0Genevieve Meier1Richard Perry2Darren Joe3Eisai Inc.Eisai Inc.Adelphi ValuesAdelphi ValuesAbstract Introduction A significant proportion of dementia is concretely estimated to be attributable to dementia with Lewy bodies (DLB)—one of the most common types of progressive dementia; however, there is a paucity of literature on this disease. We aimed to examine available evidence to gain a better understanding of its treatment landscape, clinical management, and disease burden. Methods A systematic literature review captured any DLB studies that report on randomised controlled trials (RCTs), epidemiology, disease progression, and economic data. An additional targeted literature review captured studies reporting on clinical management and quality of life (QoL) in this disease. Publication date was limited to 1 January 2007–26 March 2018, with the exception for RCTs, where no time restrictions were applied. Findings Of the 3486 studies initially identified, 55 studies were eligible for inclusion. The studies were mainly from Europe (n = 29), the USA (n = 9), and Japan (n = 8). Mini-Mental State Examination and Neuropsychiatric Inventory scores were the most commonly reported clinical outcomes in RCTs (n = 14). The most frequently identified interventions reported in RCTs were donepezil and memantine. Patients with DLB typically reported worse outcomes in relation to efficacy and safety, cognitive impairment, survival, and QoL compared with those with Alzheimer’s disease (AD). Additionally, patients with DLB were associated with higher hospitalisation rates and cost of care. Furthermore, there is a reliance on a small number of consensus guidelines. Of these, only one set of guidelines (DLB Consortium) was developed specifically for DLB. Conclusion The paucity of data indicates an unmet need in this therapy area. Although several studies look into the clinical and pathological aspects of DLB, consensus guidelines and studies on healthcare utilisation in patients with dementia have largely focused on AD. Additionally, most of the findings were made in comparison with AD. Funding Eisai Inc.http://link.springer.com/article/10.1007/s40120-019-00154-7Burden of diseaseClinical managementDementiaDementia with Lewy bodiesHealthcare resource utilisationHealthcare costs
spellingShingle Amir Abbas Tahami Monfared
Genevieve Meier
Richard Perry
Darren Joe
Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
Neurology and Therapy
Burden of disease
Clinical management
Dementia
Dementia with Lewy bodies
Healthcare resource utilisation
Healthcare costs
title Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
title_full Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
title_fullStr Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
title_full_unstemmed Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
title_short Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review
title_sort burden of disease and current management of dementia with lewy bodies a literature review
topic Burden of disease
Clinical management
Dementia
Dementia with Lewy bodies
Healthcare resource utilisation
Healthcare costs
url http://link.springer.com/article/10.1007/s40120-019-00154-7
work_keys_str_mv AT amirabbastahamimonfared burdenofdiseaseandcurrentmanagementofdementiawithlewybodiesaliteraturereview
AT genevievemeier burdenofdiseaseandcurrentmanagementofdementiawithlewybodiesaliteraturereview
AT richardperry burdenofdiseaseandcurrentmanagementofdementiawithlewybodiesaliteraturereview
AT darrenjoe burdenofdiseaseandcurrentmanagementofdementiawithlewybodiesaliteraturereview